Drugs / ketorlac
Trials 0
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Comparator or background therapy1 trial | ||||||
| — | NCT06036979 Background | Jul → Oct 2024 | chronic pain syndrome | National Cancer Institute, Egypt | Unknown | No outcome recorded |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | ketorlac | ClinicalTrials.gov intervention name — accepted as the source's own label NCT06036979 ↗ |
| Route | Intravenous | “intravenous ketorlac” NCT06036979 ↗ |